{"meta":{"query_hash":"a5f00f5690e7","filters":{"venue":"CNS & Neurological Disorders - Drug Targets"},"cohort_total":41,"direct_labels_cover":0,"predictions_cover":41,"exported":41,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a5f00f5690e7","api":"https://metacan.xera.ac/api/v1/cohort?venue=CNS+%26+Neurological+Disorders+-+Drug+Targets"},"results":[{"id":"W1977672801","doi":"10.2174/187152711797247795","title":"The Surgical Management of Parkinson's Disease","year":2011,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neurological disorders and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital","funders":"","keywords":"Deep brain stimulation; Levodopa; Parkinson's disease; Medicine; Disease; Movement disorders; Adverse effect; Motor symptoms; Dopaminergic; Subthalamic nucleus; Physical medicine and rehabilitation; Intensive care medicine; Surgery; Dopamine; Internal medicine","score_opus":0.03254448623468187,"score_gpt":0.2975014130911173,"score_spread":0.2649569268564354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977672801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016909456,0.99825484,0.00008816096,0.00013216643,0.00013830846,0.0000028974182,0.000005638302,0.000005901253,0.0012031092],"genre_scores_gemma":[0.0009792225,0.9979259,0.00014156978,0.00012444294,0.00018823954,0.0000028545426,0.000014587039,0.000001370266,0.00062171946],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998349,0.000026924177,0.000023450582,0.000026298749,0.00007472022,0.00001359611],"domain_scores_gemma":[0.9998337,0.00007215912,0.000033281933,0.000005735844,0.00003801641,0.00001714904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034190353,0.0008512269,0.0011093837,0.0024683117,0.0003484863,0.0007198183,0.0005904121,0.0008827342,0.003192257],"category_scores_gemma":[0.00047206494,0.00018413871,0.0004045831,0.0017367053,0.00059258734,0.00085445505,0.0005649802,0.001307063,0.0021834155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003371215,0.000043442345,0.00016536703,0.0067631896,0.00005252996,0.0004388063,0.000054808228,0.00019450336,0.0008238662,0.001330705,0.02331293,0.966786],"study_design_scores_gemma":[0.000029174893,0.00013052991,0.002608957,0.0057385503,0.000095902215,0.0112065775,0.00014690043,0.00014953259,0.0006396527,0.0029734178,0.9762526,0.000028206574],"about_ca_topic_score_codex":0.0011628484,"about_ca_topic_score_gemma":0.002353252,"teacher_disagreement_score":0.003192257,"about_ca_system_score_codex":0.00043956793,"about_ca_system_score_gemma":0.0007209267,"threshold_uncertainty_score":0.010679126},"labels":[],"label_agreement":null},{"id":"W1980970141","doi":"10.2174/187152708784083821","title":"Ionotropic Glutamate Receptors & CNS Disorders","year":2008,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Genetics and Neurodevelopmental Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Institute of Mental Health","keywords":"Kainate receptor; Neuroscience; AMPA receptor; Ionotropic effect; Glutamate receptor; Neurotransmitter receptor; Epileptogenesis; Epilepsy; Biology; Receptor; Long-term depression; Neurotransmitter; Central nervous system; Genetics","score_opus":0.01782932616566039,"score_gpt":0.2633236510123453,"score_spread":0.2454943248466849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980970141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012164969,0.9923137,0.00028744747,0.0005450625,0.0006819355,0.0000073643346,0.000016404501,0.00002423573,0.0060022636],"genre_scores_gemma":[0.0010433036,0.99336326,0.00042652382,0.00047356,0.00042520105,0.000012877435,0.000031854,0.0000035727644,0.0042198873],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998473,0.000030238138,0.000016710379,0.000028975506,0.00006078397,0.000015995554],"domain_scores_gemma":[0.99985576,0.00005830799,0.000017734881,0.0000071423237,0.000041715135,0.00001926501],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033943963,0.0013886258,0.0012223107,0.0016187762,0.00039616448,0.00093361613,0.00093909167,0.0013767744,0.0057449057],"category_scores_gemma":[0.00046095686,0.000243273,0.00033446314,0.0018211997,0.00065101724,0.0014554122,0.00065868895,0.0016423451,0.008420933],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006357633,0.000066653476,0.00019153894,0.005060799,0.00004404845,0.00079217117,0.00007850584,0.00032715977,0.001656203,0.0061181528,0.07704253,0.9085585],"study_design_scores_gemma":[0.000012259964,0.000024957571,0.00035655402,0.000950323,0.00002160384,0.0024238147,0.000045535828,0.000038581387,0.00019892988,0.002507842,0.9934111,0.000008299021],"about_ca_topic_score_codex":0.0010164038,"about_ca_topic_score_gemma":0.0017405603,"teacher_disagreement_score":0.0057449057,"about_ca_system_score_codex":0.00071877125,"about_ca_system_score_gemma":0.0008106488,"threshold_uncertainty_score":0.019218624},"labels":[],"label_agreement":null},{"id":"W1988723814","doi":"10.2174/1871527313666141130204031","title":"Towards a “Metabolic” Subtype of Major Depressive Disorder: Shared Pathophysiological Mechanisms May Contribute to Cognitive Dysfunction","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Stress Responses and Cortisol","field":"Neuroscience","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Major depressive disorder; Bipolar disorder; Bioinformatics; Medicine; Metabolic syndrome; Diabetes mellitus; Obesity; Internal medicine; Psychology; Cognition; Endocrinology; Psychiatry; Biology","score_opus":0.03678062935925655,"score_gpt":0.3057794265150174,"score_spread":0.2689987971557608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988723814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0130149275,0.9785734,0.0007679946,0.0035297778,0.00039066328,0.000105142484,0.0005645765,0.00001037813,0.0030431882],"genre_scores_gemma":[0.08237502,0.91002417,0.002490127,0.003124089,0.00047982778,0.000110698216,0.0006383062,0.0000037282273,0.00075408176],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996051,0.00010685503,0.0001477977,0.000047491936,0.00006964538,0.000023193363],"domain_scores_gemma":[0.9993942,0.00023248664,0.00023096049,0.000012275833,0.00011080201,0.000019190726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006380812,0.00029847847,0.00086425984,0.0014979666,0.00028170567,0.0009636332,0.0003772344,0.00060355663,0.0017664976],"category_scores_gemma":[0.0016683756,0.00014304952,0.00088945386,0.0023275486,0.00032210315,0.0009505176,0.00039663815,0.0006000984,0.00029818155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070340093,0.00009666365,0.038620934,0.23551288,0.0043699928,0.0034976348,0.0016284294,0.00037596445,0.005517849,0.009507543,0.03102744,0.6691413],"study_design_scores_gemma":[0.0005180825,0.0009208801,0.22709295,0.16281633,0.015637733,0.035806317,0.005162407,0.0008745896,0.002555203,0.015974032,0.5325145,0.00012699726],"about_ca_topic_score_codex":0.0025827042,"about_ca_topic_score_gemma":0.008190276,"teacher_disagreement_score":0.0025827042,"about_ca_system_score_codex":0.00057693385,"about_ca_system_score_gemma":0.0016378032,"threshold_uncertainty_score":0.005909562},"labels":[],"label_agreement":null},{"id":"W2006163739","doi":"10.2174/187152711799219398","title":"Interception of Cocaine by Enzyme or Antibody Delivered with Viral Gene Transfer: A Novel Strategy for Preventing Relapse in Recovering Drug Users","year":2011,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Ottawa; National Institute on Drug Abuse; Baylor University; University of Minnesota","keywords":"Butyrylcholinesterase; Viral vector; Monoclonal antibody; Drug; Pharmacology; Antibody; Virology; Vector (molecular biology); Addiction; Enzyme; Immunology; Biology; Chemistry; Medicine; Gene; Recombinant DNA; Biochemistry; Neuroscience","score_opus":0.03723339154334581,"score_gpt":0.32204500976020106,"score_spread":0.28481161821685524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006163739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001680697,0.99411917,0.0012594664,0.00032432616,0.00016152635,0.000020035108,0.000022872477,0.000024848352,0.0023871236],"genre_scores_gemma":[0.0064704763,0.98977953,0.0011671614,0.00016629741,0.000083998355,0.00002335112,0.000034000248,0.0000036795775,0.0022714385],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999461,0.000007259012,0.000005122093,0.000012407098,0.000022159405,0.000006950485],"domain_scores_gemma":[0.9999566,0.000017370805,0.000009144121,0.0000018492456,0.000009162994,0.000005790878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023177743,0.0005291805,0.0007010812,0.001078829,0.00016044649,0.00046909967,0.00054310897,0.0009047679,0.0015694697],"category_scores_gemma":[0.00014944174,0.00014964107,0.00026135848,0.0006569483,0.00035373034,0.0005866541,0.0002495333,0.0008381879,0.0013203745],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000072299175,0.00016446345,0.00020145236,0.0046485765,0.000056914716,0.00029727502,0.000046696685,0.0003561401,0.024807913,0.003971443,0.006753188,0.95862377],"study_design_scores_gemma":[0.00007487147,0.00062217755,0.0020379317,0.0012759943,0.00013391934,0.0044245846,0.00008734166,0.00036293062,0.020194406,0.0019793722,0.968763,0.000043496406],"about_ca_topic_score_codex":0.00079306343,"about_ca_topic_score_gemma":0.0016642775,"teacher_disagreement_score":0.0015694697,"about_ca_system_score_codex":0.00047127006,"about_ca_system_score_gemma":0.00046650087,"threshold_uncertainty_score":0.005250454},"labels":[],"label_agreement":null},{"id":"W2008196551","doi":"10.2174/1871527314666150217122305","title":"Interferon-γ-Induced Neurotoxicity of Human Astrocytes","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Neurotoxicity; Astrocyte; Astrogliosis; Microglia; STAT protein; Neuroinflammation; STAT3; Biology; Janus kinase; Neurodegeneration; Cell biology; Neuroscience; Chemistry; Medicine; Signal transduction; Immunology; Inflammation; Central nervous system; Pathology; Internal medicine; Disease","score_opus":0.12466034333189112,"score_gpt":0.3603726000722367,"score_spread":0.23571225674034557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008196551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027283805,0.9969543,0.0001404955,0.00013328205,0.00013432115,0.000007679881,0.00003951355,0.000010161195,0.0023073098],"genre_scores_gemma":[0.001056268,0.99706155,0.00019170971,0.000098603654,0.00006363435,0.000009382075,0.00006269811,0.0000017425979,0.0014543798],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993336,0.000007947442,0.0000118484995,0.000011708851,0.00002656935,0.000008638673],"domain_scores_gemma":[0.9999347,0.000020279807,0.00001374769,0.0000022911483,0.000019990031,0.000009045564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002481681,0.00076013146,0.0007931277,0.0015625814,0.00020361539,0.0005818013,0.0004159975,0.0005263639,0.0028068654],"category_scores_gemma":[0.00019638908,0.0002044722,0.00030958935,0.0014173372,0.00024829613,0.00062329654,0.00046539446,0.0007516279,0.0029085046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066788365,0.000050587732,0.00015163019,0.011110374,0.000046193905,0.00023388788,0.000045027573,0.00025207223,0.0057791416,0.0022341812,0.021294065,0.95873606],"study_design_scores_gemma":[0.000016626673,0.000075734875,0.0012096554,0.0025390373,0.00006675521,0.0016013354,0.00005320327,0.00007684848,0.0019536547,0.0018595658,0.99053127,0.000016381471],"about_ca_topic_score_codex":0.00082016067,"about_ca_topic_score_gemma":0.0017028174,"teacher_disagreement_score":0.0028068654,"about_ca_system_score_codex":0.00037781295,"about_ca_system_score_gemma":0.00055019796,"threshold_uncertainty_score":0.009389937},"labels":[],"label_agreement":null},{"id":"W2050837748","doi":"10.2174/1871527313666141130204535","title":"Major Depressive Disorder and Type II Diabetes Mellitus: Mechanisms Underlying Risk for Alzheimer’s Disease","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Disease; Medicine; Type 2 Diabetes Mellitus; Diabetes mellitus; Cognition; Neurodegeneration; Alzheimer's disease; Insulin resistance; Depression (economics); Major depressive disorder; Type 2 diabetes; Comorbidity; Cognitive decline; Psychiatry; Psychology; Dementia; Internal medicine; Endocrinology","score_opus":0.06917791278279671,"score_gpt":0.319807305493071,"score_spread":0.2506293927102743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050837748","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008677402,0.99959594,0.000014839383,0.0000889594,0.000033093824,0.0000024031503,0.000009945669,0.0000011601077,0.00016697522],"genre_scores_gemma":[0.0011862902,0.9985733,0.00004402045,0.00006140641,0.000046362824,0.0000037966006,0.000013363409,2.4341972e-7,0.00007113628],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974793,0.000058129866,0.00006846956,0.0000395942,0.00006668793,0.000019035535],"domain_scores_gemma":[0.9994728,0.0002518184,0.00016083395,0.000008225935,0.00008349592,0.00002279169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005868878,0.00062378176,0.0012734352,0.002389177,0.00020338468,0.0009422716,0.0006159924,0.0008320585,0.0026144912],"category_scores_gemma":[0.0011177592,0.00020034844,0.0007233901,0.0026435342,0.00028700783,0.00074520544,0.00041562907,0.00057451014,0.0006861067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014036497,0.00005009217,0.0018665696,0.124498315,0.000804698,0.0004131503,0.00014613586,0.00028148902,0.0007321197,0.0023788903,0.015978549,0.85270965],"study_design_scores_gemma":[0.00011273016,0.0003111609,0.024922777,0.14570242,0.0041662278,0.010085171,0.0007485498,0.00032805142,0.0008199898,0.0054416833,0.8072875,0.00007367095],"about_ca_topic_score_codex":0.0018110451,"about_ca_topic_score_gemma":0.0033359304,"teacher_disagreement_score":0.0026144912,"about_ca_system_score_codex":0.0005071186,"about_ca_system_score_gemma":0.0016456704,"threshold_uncertainty_score":0.008746386},"labels":[],"label_agreement":null},{"id":"W2072316081","doi":"10.2174/187152709789824624","title":"The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders","year":2009,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Endocannabinoid system; Anxiety; Anxiolytic; Neuroscience; 2-Arachidonoylglycerol; Mood disorders; Psychology; Cannabinoid receptor; Mood; Anxiogenic; Panic disorder; Medicine; Clinical psychology; Psychiatry; Receptor; Internal medicine","score_opus":0.01303902948591368,"score_gpt":0.28566998542731487,"score_spread":0.2726309559414012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072316081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027211092,0.99716705,0.000081894716,0.00020905014,0.00014875097,0.000008154196,0.000014170781,0.00000590423,0.0020928853],"genre_scores_gemma":[0.0012599549,0.99656206,0.00023159513,0.00015228453,0.0001374997,0.000007548353,0.000022951172,9.869308e-7,0.0016251331],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998553,0.000024398645,0.000016388662,0.000018521652,0.00007179852,0.000013698308],"domain_scores_gemma":[0.9999057,0.000030851625,0.000017913217,0.000003122451,0.00002921227,0.000013172741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003400565,0.00056640693,0.0009396865,0.0019998148,0.0003266764,0.0005637038,0.00064691255,0.000891559,0.004709215],"category_scores_gemma":[0.00032929174,0.00015415304,0.00029665572,0.0017179421,0.00032127358,0.00060964737,0.00043274122,0.0009860881,0.002698244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009942506,0.00014574133,0.00015171981,0.008193585,0.000066420245,0.00040536223,0.00006574278,0.0002792109,0.0027665063,0.0021107113,0.019487213,0.9662284],"study_design_scores_gemma":[0.00004599043,0.00017250386,0.0017821819,0.0025298842,0.00008819353,0.0024571626,0.00011258199,0.000105580206,0.000818891,0.001883661,0.989986,0.000017310973],"about_ca_topic_score_codex":0.0018859719,"about_ca_topic_score_gemma":0.0046779644,"teacher_disagreement_score":0.004709215,"about_ca_system_score_codex":0.0005355868,"about_ca_system_score_gemma":0.00092866394,"threshold_uncertainty_score":0.015753865},"labels":[],"label_agreement":null},{"id":"W2072969565","doi":"10.2174/187152706776359592","title":"Neuropeptide Y: Role in Emotion and Alcohol Dependence","year":2006,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neuropeptides and Animal Physiology","field":"Neuroscience","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Institute of Neurosciences, Mental Health and Addiction; Douglas Mental Health University Institute","funders":"","keywords":"Neuropeptide Y receptor; Anxiety; Addiction; Alcohol dependence; Mood; Psychology; Emotionality; Neuropeptide; Etiology; Alcohol addiction; Depression (economics); Mood disorders; Alcohol; Neuroscience; Clinical psychology; Psychiatry; Medicine; Internal medicine; Receptor; Biology","score_opus":0.03701121602750944,"score_gpt":0.29256078316864614,"score_spread":0.2555495671411367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072969565","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020055531,0.9984059,0.00008260167,0.000104022416,0.000098965116,0.0000020825692,0.0000072268967,0.0000046280466,0.0010941186],"genre_scores_gemma":[0.0013027027,0.99695694,0.00013916712,0.00009617053,0.00010857134,0.0000047125136,0.00001355037,0.0000010249335,0.0013770525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999157,0.000013400416,0.000010175539,0.000016374186,0.000033679553,0.000010672684],"domain_scores_gemma":[0.9999349,0.000018858478,0.0000116462925,0.0000022320805,0.000018711862,0.000013628121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002554342,0.0007822571,0.001023802,0.0008342134,0.00027263453,0.0007177725,0.00059531117,0.00097509206,0.003163106],"category_scores_gemma":[0.0002030675,0.00015393301,0.00020035895,0.0012802046,0.00045962277,0.0008294643,0.00060210074,0.0009455424,0.0029206073],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091991256,0.00006592306,0.00025637023,0.005505179,0.000040192102,0.00045123094,0.00007452166,0.00024374943,0.003935391,0.0022506781,0.01585236,0.9712324],"study_design_scores_gemma":[0.000034477005,0.00017002042,0.003246652,0.0026520418,0.00006790107,0.004426989,0.00016554316,0.00009684266,0.0010622478,0.0041907327,0.9838668,0.00001976409],"about_ca_topic_score_codex":0.0009922175,"about_ca_topic_score_gemma":0.0015873422,"teacher_disagreement_score":0.003163106,"about_ca_system_score_codex":0.00039777526,"about_ca_system_score_gemma":0.0006715094,"threshold_uncertainty_score":0.010581613},"labels":[],"label_agreement":null},{"id":"W2076096323","doi":"10.2174/18715273113126660177","title":"Screening for Inhibitors of Microglia to Reduce Neuroinflammation","year":2013,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Microglia; Neuroinflammation; Lipopolysaccharide; Pharmacology; Neurotoxicity; Chemistry; Cytotoxicity; Tumor necrosis factor alpha; Multiple sclerosis; Toxicity; Inflammation; Medicine; Immunology; Biochemistry; Internal medicine; In vitro","score_opus":0.026872792362493618,"score_gpt":0.26100086912749465,"score_spread":0.23412807676500103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076096323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91611415,0.059309233,0.009805807,0.00069383415,0.0002011851,0.0010125894,0.0027428812,0.00039236396,0.009727875],"genre_scores_gemma":[0.9316521,0.03992955,0.014809432,0.0008221568,0.00011953901,0.00050850055,0.0041116043,0.00006327374,0.007983832],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99982363,0.000031171567,0.0000161042,0.000028218854,0.00006518266,0.000035746354],"domain_scores_gemma":[0.99982953,0.000029700439,0.000042568714,0.000010204105,0.00005810884,0.00002976279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003691546,0.00079794717,0.00057634606,0.00096390274,0.00019753673,0.0003366839,0.00038111437,0.00042810375,0.0023722437],"category_scores_gemma":[0.00023419989,0.0002061886,0.00066616945,0.00045698188,0.00019060641,0.00023713395,0.00024084028,0.00051568577,0.00081153447],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000543714,0.0004887797,0.0011078365,0.00091475475,0.00008720509,0.0003527501,0.000060710416,0.001083393,0.9683678,0.00019932853,0.00076819526,0.026025664],"study_design_scores_gemma":[0.00074677134,0.022227282,0.013382804,0.00044766857,0.0005765453,0.0021485682,0.00010924793,0.0021844897,0.92326117,0.0003250889,0.034519747,0.000070640104],"about_ca_topic_score_codex":0.00038753005,"about_ca_topic_score_gemma":0.0015900182,"teacher_disagreement_score":0.0023722437,"about_ca_system_score_codex":0.00028919533,"about_ca_system_score_gemma":0.00041479373,"threshold_uncertainty_score":0.007935941},"labels":[],"label_agreement":null},{"id":"W2077763826","doi":"10.2174/1871527313666141130204300","title":"Are Major Depressive Disorder and Diabetes Mellitus Amyloidogenic Conditions?","year":2015,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Diabetes mellitus; Major depressive disorder; Medicine; Internal medicine; Psychiatry; Endocrinology","score_opus":0.012278268091867248,"score_gpt":0.2494469824247118,"score_spread":0.23716871433284456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077763826","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07417866,0.76536727,0.0012694868,0.12159778,0.00782106,0.00008553365,0.00096680305,0.000046008274,0.028667478],"genre_scores_gemma":[0.4412212,0.48665756,0.0012204518,0.039993558,0.021593995,0.00009230742,0.00092095335,0.000012362403,0.0082875565],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99930084,0.00016732838,0.00013353438,0.00014358017,0.00013756315,0.00011711342],"domain_scores_gemma":[0.99863154,0.00042244667,0.00047839314,0.000047327914,0.00020391186,0.0002162933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006935466,0.00038173073,0.0009887706,0.00094012293,0.00063398975,0.0014267117,0.0005144216,0.0022043777,0.0061002034],"category_scores_gemma":[0.003567016,0.00024206338,0.00059257355,0.001617188,0.001007717,0.0016194616,0.00084964914,0.0017322873,0.0009737094],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014751152,0.00034377145,0.4033176,0.0051682154,0.00097270147,0.017470863,0.0018557542,0.00020905367,0.0011624343,0.030436495,0.07422916,0.46335876],"study_design_scores_gemma":[0.00024045953,0.00037985662,0.5550803,0.0070541427,0.0008506872,0.09465613,0.003993771,0.00054952834,0.00026901928,0.0387555,0.2980429,0.00012768652],"about_ca_topic_score_codex":0.0041563585,"about_ca_topic_score_gemma":0.0045014108,"teacher_disagreement_score":0.0061002034,"about_ca_system_score_codex":0.0007312692,"about_ca_system_score_gemma":0.0010354202,"threshold_uncertainty_score":0.0204072},"labels":[],"label_agreement":null},{"id":"W2080824561","doi":"10.2174/1871527313666141130205024","title":"The Putative Impact of Metabolic Health on Default Mode Network Activity and Functional Connectivity in Neuropsychiatric Disorders","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Default mode network; Neuroscience; Psychology; Cognition; Resting state fMRI; Neuroimaging; Mood disorders; Functional connectivity; Functional neuroimaging; Mood; Functional magnetic resonance imaging; Psychiatry","score_opus":0.0517798153738261,"score_gpt":0.34839878269880165,"score_spread":0.29661896732497556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080824561","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02700823,0.96490455,0.0023956364,0.0015863656,0.00022206105,0.000021450529,0.00026971387,0.000030062267,0.0035619298],"genre_scores_gemma":[0.15621884,0.8386732,0.0023007195,0.00077508856,0.0005602501,0.00005295415,0.00034067297,0.000006944649,0.0010712846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990296,0.000027920945,0.000016929613,0.000025297706,0.000012983431,0.000013850953],"domain_scores_gemma":[0.99981266,0.00010467996,0.000045732773,0.0000048369884,0.000019976005,0.000012082275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032227914,0.0002719637,0.00046305006,0.00073373225,0.00013708262,0.00067081867,0.00035578373,0.0005231971,0.0010239434],"category_scores_gemma":[0.0007293233,0.00010639975,0.00038609983,0.00051693554,0.00036019544,0.00051397533,0.00035343488,0.00047054153,0.00009219755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094501715,0.00008587628,0.026364017,0.03071248,0.0017321557,0.0034172295,0.0016125747,0.002409117,0.023098214,0.026686352,0.0110396445,0.87189734],"study_design_scores_gemma":[0.00018390873,0.0014141571,0.43638736,0.016822778,0.004834616,0.03213509,0.0017802988,0.0041547646,0.011370381,0.073045544,0.41759235,0.00027879112],"about_ca_topic_score_codex":0.0011652735,"about_ca_topic_score_gemma":0.0023769734,"teacher_disagreement_score":0.0011652735,"about_ca_system_score_codex":0.00046810534,"about_ca_system_score_gemma":0.0004621505,"threshold_uncertainty_score":0.0034254193},"labels":[],"label_agreement":null},{"id":"W2086267455","doi":"10.2174/18715273113129990095","title":"Suicide and the Polyamine System","year":2013,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Polyamine Metabolism and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Douglas Mental Health University Institute","funders":"Canadian Institutes of Health Research","keywords":"Polyamine; Dysfunctional family; Intervention (counseling); Neuroscience; Psychology; Human factors and ergonomics; Poison control; Psychiatry; Medicine; Clinical psychology; Biology; Medical emergency; Genetics","score_opus":0.014217583116360014,"score_gpt":0.26785134857006265,"score_spread":0.25363376545370264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086267455","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021850121,0.9983417,0.00009429823,0.00025140727,0.000083006584,0.0000025984507,0.000009423696,0.0000061728006,0.0009928605],"genre_scores_gemma":[0.0015292622,0.9975358,0.00010983194,0.0001075485,0.00007829351,0.0000041282437,0.000015283124,7.216864e-7,0.0006191799],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99991655,0.000016648719,0.000010413873,0.00001479345,0.000031405903,0.000010285247],"domain_scores_gemma":[0.9999083,0.00002744013,0.000017557932,0.000003156206,0.000028505397,0.000015050039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022940234,0.00052060635,0.00079257763,0.0010802118,0.00032105035,0.00063804415,0.00041630853,0.0009220945,0.002375991],"category_scores_gemma":[0.00023108325,0.00013251902,0.00027322862,0.00091944024,0.0004342787,0.0006042269,0.00058664853,0.0009810635,0.0014357864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051095205,0.00005569548,0.0003756723,0.007522667,0.000068128466,0.000325995,0.00007337291,0.0001896973,0.0034081768,0.0050236653,0.014754289,0.9681514],"study_design_scores_gemma":[0.000015927484,0.00017783217,0.0026302326,0.0028200252,0.00008426587,0.0036519675,0.00013035841,0.00010304953,0.0014492613,0.0040658065,0.9848496,0.000021736763],"about_ca_topic_score_codex":0.001362195,"about_ca_topic_score_gemma":0.0024584201,"teacher_disagreement_score":0.002375991,"about_ca_system_score_codex":0.00050281215,"about_ca_system_score_gemma":0.00093225803,"threshold_uncertainty_score":0.007948458},"labels":[],"label_agreement":null},{"id":"W2093777439","doi":"10.2174/18715273113126660197","title":"Subcellular Injuries in Alzheimer’s Disease","year":2014,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital","funders":"","keywords":"Neurodegeneration; Endosome; Golgi apparatus; Endoplasmic reticulum; Cell biology; Biology; Programmed cell death; Mitochondrion; Neuroscience; Neuroinflammation; Alzheimer's disease; Subcellular localization; Microglia; Intracellular; Pathology; Disease; Medicine; Inflammation; Immunology; Apoptosis; Biochemistry; Cytoplasm","score_opus":0.04214750574567525,"score_gpt":0.34035412586939084,"score_spread":0.29820662012371557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093777439","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011438923,0.99848807,0.00006680574,0.00010633837,0.00013469942,0.0000049611945,0.000011197212,0.0000073699493,0.0010661329],"genre_scores_gemma":[0.0007010489,0.9984438,0.000107995795,0.00007987853,0.00008101883,0.000004184106,0.000017603721,8.146657e-7,0.00056372216],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99984217,0.000021603888,0.000026043563,0.00002492314,0.00006943757,0.00001565765],"domain_scores_gemma":[0.9998721,0.000036810954,0.000026269796,0.000004488398,0.000044907298,0.000015448255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030621243,0.0009936137,0.0011794509,0.0029529752,0.00039491113,0.0008863764,0.0006015016,0.0010624339,0.0031851258],"category_scores_gemma":[0.00038498236,0.00023774452,0.00041846605,0.002844259,0.00046595067,0.0012767786,0.0007344962,0.0012486314,0.002686577],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059262187,0.00008077678,0.0002375457,0.024211807,0.000070922746,0.00039776182,0.00013210747,0.000293032,0.0023940117,0.0034072816,0.030416679,0.9382988],"study_design_scores_gemma":[0.000015169117,0.0001055794,0.001341738,0.0046130912,0.00009305761,0.0032739432,0.00011994765,0.000056133897,0.00048050444,0.0030589276,0.98682356,0.000018166485],"about_ca_topic_score_codex":0.0012125497,"about_ca_topic_score_gemma":0.0020393934,"teacher_disagreement_score":0.0031851258,"about_ca_system_score_codex":0.00054321095,"about_ca_system_score_gemma":0.001067801,"threshold_uncertainty_score":0.010655284},"labels":[],"label_agreement":null},{"id":"W2103056916","doi":"10.2174/1871527315666151111125533","title":"Adult neurogenic and antidepressant effects of adiponectin: a potential replacement for exercise?","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Adipose Tissue and Metabolism","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Adiponectin; Neurogenesis; Antidepressant; Hippocampal formation; Neuroscience; Medicine; Physical exercise; Hippocampus; Central nervous system; Internal medicine; Bioinformatics; Psychology; Biology; Obesity; Insulin resistance","score_opus":0.018081855232162047,"score_gpt":0.300224212668447,"score_spread":0.28214235743628496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103056916","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029246302,0.9983911,0.00014115155,0.0003220298,0.00014212099,0.0000038156886,0.000018283106,0.0000047529784,0.00068423833],"genre_scores_gemma":[0.0018230019,0.996842,0.00029842678,0.00019329296,0.00012828042,0.0000058788573,0.000028330769,0.0000012653669,0.0006795408],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99993086,0.00001301203,0.00001180589,0.0000147386,0.00002152385,0.000007989507],"domain_scores_gemma":[0.99992263,0.000032765045,0.000013065565,0.0000037956156,0.000019151566,0.000008548708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028384005,0.0005166356,0.00086833426,0.0011780148,0.0002075652,0.0006389569,0.00048179296,0.00076588104,0.0031348804],"category_scores_gemma":[0.0002756594,0.00017584347,0.00040056696,0.00089075824,0.00035740275,0.00084460696,0.0004530801,0.0012620817,0.0014509204],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012975247,0.00011791697,0.00022285391,0.019220443,0.00012819044,0.0003755461,0.00009998182,0.0002752776,0.007498033,0.0063246232,0.015514513,0.9500929],"study_design_scores_gemma":[0.00003844382,0.0002065836,0.0011148682,0.0038178794,0.00013098946,0.0016938366,0.00010818597,0.00012537483,0.0017459107,0.0033337723,0.98766255,0.000021617372],"about_ca_topic_score_codex":0.0005289879,"about_ca_topic_score_gemma":0.0014093388,"teacher_disagreement_score":0.0031348804,"about_ca_system_score_codex":0.00021217769,"about_ca_system_score_gemma":0.0003917879,"threshold_uncertainty_score":0.010487199},"labels":[],"label_agreement":null},{"id":"W2115352418","doi":"10.2174/187152710793361612","title":"Group I Metabotropic Glutamate Receptor Signalling and its Implication in Neurological Disease","year":2010,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neuroscience and Neuropharmacology Research","field":"Neuroscience","cited_by":153,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Canadian Institutes of Health Research","keywords":"Metabotropic glutamate receptor 1; Metabotropic glutamate receptor; Metabotropic glutamate receptor 5; Metabotropic glutamate receptor 7; Metabotropic glutamate receptor 3; Metabotropic glutamate receptor 6; Neuroscience; Metabotropic glutamate receptor 4; Biology; Signal transduction; Metabotropic receptor; Cell biology; Glutamate receptor; Receptor; Biochemistry","score_opus":0.054926444268437215,"score_gpt":0.34755457559163294,"score_spread":0.2926281313231957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115352418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020367316,0.997532,0.00011755691,0.00018434059,0.000119680524,0.000003898428,0.000013910372,0.000007544338,0.0018173327],"genre_scores_gemma":[0.0008250585,0.99758637,0.00019551488,0.000099208344,0.00010921007,0.000005041825,0.000023032635,0.0000010021946,0.0011555863],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990916,0.000015306136,0.00001294143,0.00001627005,0.0000367068,0.000009595616],"domain_scores_gemma":[0.99993205,0.000020000276,0.000011475799,0.00000266132,0.000021946616,0.0000118544285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026625185,0.0007296341,0.0009845757,0.001506315,0.0002659687,0.00066488405,0.0006138696,0.0009371311,0.0035544506],"category_scores_gemma":[0.0002279133,0.00018173666,0.00022040073,0.0019362228,0.00036456055,0.0008833093,0.00052634365,0.00083442056,0.0037662687],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007692934,0.00007447095,0.00018350109,0.008135446,0.000048793245,0.0004773717,0.000083947096,0.00030543658,0.0049711927,0.004590438,0.024215186,0.9568373],"study_design_scores_gemma":[0.000017041959,0.00008790803,0.0012666552,0.0015635496,0.00004941725,0.0023019125,0.00008089313,0.00007147015,0.00066540303,0.0032410633,0.99064064,0.0000140524535],"about_ca_topic_score_codex":0.0009402793,"about_ca_topic_score_gemma":0.0017357614,"teacher_disagreement_score":0.0035544506,"about_ca_system_score_codex":0.00055169745,"about_ca_system_score_gemma":0.0006948565,"threshold_uncertainty_score":0.011890888},"labels":[],"label_agreement":null},{"id":"W2120826122","doi":"10.2174/187152709788921708","title":"Neuroimaging of Narcolepsy","year":2009,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Sleep and Wakefulness Research","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Narcolepsy; Sleep paralysis; Neuroimaging; Cataplexy; Orexin; Neuroscience; Psychology; Sleep (system call); Modafinil; Sleep disorder; Neurology; Medicine; Psychiatry; Cognition; Neuropeptide; Internal medicine","score_opus":0.0669980344414897,"score_gpt":0.35044513283233425,"score_spread":0.28344709839084453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120826122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036611984,0.9955076,0.00027185035,0.00037488365,0.00016100841,0.00001088195,0.00002150908,0.000012729327,0.0032734186],"genre_scores_gemma":[0.0027004187,0.9942253,0.00046970096,0.000380054,0.0003820873,0.000012967974,0.000054845514,0.0000030704855,0.0017715447],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998909,0.000027945118,0.000014390937,0.000021811324,0.000034911947,0.000009901391],"domain_scores_gemma":[0.999879,0.000044932454,0.00001964332,0.0000067416713,0.000038757884,0.000010905318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003342636,0.0010165181,0.0012924063,0.0024839137,0.00018288256,0.00052944414,0.0006022835,0.0014672218,0.0019364097],"category_scores_gemma":[0.00048909313,0.00022249208,0.00036302797,0.0013010212,0.0005036115,0.0007885627,0.00047893802,0.0009875806,0.0018398585],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063644715,0.000045973302,0.00072839396,0.009102975,0.00014856833,0.0040253634,0.00015813371,0.00028563075,0.0061235456,0.002828511,0.042560752,0.9339284],"study_design_scores_gemma":[0.000043875294,0.00011733734,0.016528111,0.007461038,0.00017437073,0.0715241,0.0002550205,0.0002836288,0.0016840056,0.005008619,0.8968676,0.000052333173],"about_ca_topic_score_codex":0.0031337882,"about_ca_topic_score_gemma":0.0067408225,"teacher_disagreement_score":0.0031337882,"about_ca_system_score_codex":0.00065958285,"about_ca_system_score_gemma":0.00060441525,"threshold_uncertainty_score":0.006477952},"labels":[],"label_agreement":null},{"id":"W2126294745","doi":"10.2174/1871527313999140312150358","title":"Conference Report: 6<sup>th</sup> Clinical Trials on Alzheimer’s Disease (CTAD) Conference, Nov 14-16, 2013, The Westin San Diego Gaslamp Quarter Hotel, San Diego, CA, USA","year":2014,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Gerontology; Clinical trial; Disease; Medicine; History; Internal medicine; Archaeology","score_opus":0.07630753013187468,"score_gpt":0.3482665818231732,"score_spread":0.2719590516912985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126294745","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062111076,0.03243353,0.005618682,0.21357673,0.25337127,0.009451261,0.048541754,0.0018047045,0.42899093],"genre_scores_gemma":[0.018191224,0.0146649275,0.0059762066,0.042544875,0.0639935,0.006544272,0.025663,0.0010843563,0.8213377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99647456,0.0008286711,0.00020635244,0.00037597853,0.0015106502,0.00060373894],"domain_scores_gemma":[0.9857092,0.002040757,0.00087096385,0.0003416667,0.005765887,0.0052716015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012015165,0.0016943525,0.0015194012,0.0010412917,0.001512306,0.0065225856,0.0015593746,0.0062781763,0.21845229],"category_scores_gemma":[0.011225078,0.0006165818,0.0017707616,0.0008859767,0.00058917876,0.0012839688,0.0015176545,0.004912174,0.10298808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007096959,0.000088580746,0.000121608755,0.00016464842,0.000018012153,0.00002671538,0.000006559034,0.000053264717,0.00020081336,0.00015019915,0.9896422,0.008817594],"study_design_scores_gemma":[0.0022297553,0.0006880897,0.003321315,0.0004177702,0.00007937285,0.00010294853,0.000073937925,0.0003564678,0.00076578214,0.00064804323,0.991269,0.000047529404],"about_ca_topic_score_codex":0.0046116905,"about_ca_topic_score_gemma":0.012017072,"teacher_disagreement_score":0.21845229,"about_ca_system_score_codex":0.0019725487,"about_ca_system_score_gemma":0.009060734,"threshold_uncertainty_score":0.73079574},"labels":[],"label_agreement":null},{"id":"W2130828922","doi":"10.2174/187152712800672490","title":"Janus Molecule I: Dichotomous Effects of COMT in Neuropathic vs Nociceptive Pain Modalities","year":2012,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Dental and Craniofacial Research; National Institute of Neurological Disorders and Stroke","keywords":"Neuroscience; Nociception; Neuropathic pain; Adrenergic receptor; Adrenergic; Receptor; Chronic pain; Stimulation; Medicine; Norepinephrine; Analgesic; Psychology; Internal medicine; Pharmacology; Dopamine","score_opus":0.020002868277019067,"score_gpt":0.28035427002318564,"score_spread":0.26035140174616656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130828922","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028590558,0.9981243,0.00014660871,0.00014681718,0.0001267825,0.0000048266375,0.000022782502,0.000007929092,0.0011339226],"genre_scores_gemma":[0.0017069496,0.99675,0.00025893105,0.00012994217,0.00014988495,0.000007924249,0.0000403752,0.0000019871645,0.0009540787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999114,0.000012754084,0.000015720065,0.000020270885,0.000030482952,0.0000092719465],"domain_scores_gemma":[0.9999151,0.000035037603,0.000017954862,0.0000029298544,0.000018258599,0.000010661263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021724863,0.00080662186,0.0012673277,0.0018221387,0.00025378205,0.00083701266,0.00060243567,0.00070415396,0.0025214434],"category_scores_gemma":[0.00025030487,0.0002254617,0.0003715804,0.0016990725,0.00047001318,0.0010251104,0.0005839162,0.0011503614,0.0016084028],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013951103,0.00006424852,0.0002142216,0.018224444,0.00009972857,0.0004089686,0.00008998047,0.000226533,0.008721332,0.0040324014,0.011518462,0.9562602],"study_design_scores_gemma":[0.000039519768,0.00016208281,0.0022230675,0.0029932451,0.00016715389,0.003723309,0.00012444422,0.00013336308,0.0035411445,0.0033151738,0.9835435,0.00003411863],"about_ca_topic_score_codex":0.0004681636,"about_ca_topic_score_gemma":0.0009545083,"teacher_disagreement_score":0.0025214434,"about_ca_system_score_codex":0.00037293427,"about_ca_system_score_gemma":0.00047066106,"threshold_uncertainty_score":0.00843513},"labels":[],"label_agreement":null},{"id":"W2131691977","doi":"10.2174/1871527313666141130205242","title":"Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Anxiety; Gut flora; Anxiolytic; Mood; Gut–brain axis; Mood disorders; Antidepressant; Microbiome; Probiotic; Generalized anxiety disorder; Irritable bowel syndrome; Depression (economics); Medicine; Psychology; Clinical psychology; Bioinformatics; Psychiatry; Immunology; Biology","score_opus":0.03528885005236566,"score_gpt":0.32628314907938244,"score_spread":0.2909942990270168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131691977","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001813973,0.9943968,0.0003048093,0.0020997003,0.000262854,0.0000127167,0.000043665637,0.000007910419,0.001057543],"genre_scores_gemma":[0.023045503,0.97356695,0.0010346819,0.0009925732,0.0003352955,0.00004212307,0.00006050873,0.0000037976365,0.0009186326],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997557,0.00010405989,0.000029586328,0.000033242286,0.000047615562,0.000029829924],"domain_scores_gemma":[0.9998229,0.00007450053,0.000040301828,0.00000550884,0.000038830553,0.00001800492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054124725,0.00040051446,0.00092874403,0.0007631672,0.0002218513,0.0011282574,0.00030818288,0.0008163899,0.0033983851],"category_scores_gemma":[0.0009075142,0.0001325706,0.0007569387,0.0005086634,0.00033589633,0.0007249197,0.0005893189,0.0011156593,0.000551159],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009657182,0.00028031302,0.0018617741,0.045906667,0.00086724747,0.0005769334,0.00040093064,0.00046114365,0.015010094,0.015035674,0.013445924,0.9051875],"study_design_scores_gemma":[0.0006363014,0.0029208323,0.03203113,0.050485726,0.0032642214,0.0038310443,0.0015178983,0.001205364,0.0074417433,0.04170193,0.85482866,0.00013523073],"about_ca_topic_score_codex":0.0005889059,"about_ca_topic_score_gemma":0.0014797145,"teacher_disagreement_score":0.0033983851,"about_ca_system_score_codex":0.0004037095,"about_ca_system_score_gemma":0.00081617525,"threshold_uncertainty_score":0.0113687515},"labels":[],"label_agreement":null},{"id":"W2136433713","doi":"10.2174/1871527313666141130223723","title":"Hippocampal Neurogenesis, Neurotrophic Factors and Depression: Possible Therapeutic Targets?","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Apelin-related biomedical research","field":"Medicine","cited_by":103,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Carleton University","funders":"National Institute of Mental Health","keywords":"Neurogenesis; Hippocampal formation; Neuroscience; Depression (economics); Neurotrophic factors; Brain-derived neurotrophic factor; Psychology; Neurotrophin; Hippocampus; Medicine; Internal medicine; Receptor","score_opus":0.061974671193440585,"score_gpt":0.352414879611626,"score_spread":0.2904402084181854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136433713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011876788,0.9989479,0.000044343764,0.00021702249,0.00009067747,0.0000024731855,0.000009263242,0.000003553926,0.0005660253],"genre_scores_gemma":[0.00081865606,0.9982685,0.00013792494,0.00015269201,0.000117457275,0.0000050894278,0.00001875002,7.918331e-7,0.00048006367],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990284,0.000017967539,0.000017314102,0.000018208675,0.00003213607,0.000011489152],"domain_scores_gemma":[0.9998834,0.000045791305,0.000019576026,0.0000039280367,0.000032717893,0.0000145910435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029076452,0.0006214346,0.0011252038,0.0017820827,0.00029689568,0.00093026867,0.00062165584,0.0009813168,0.004165261],"category_scores_gemma":[0.0003730091,0.00020236372,0.00036355804,0.0017654678,0.00035056873,0.0011551556,0.0005827131,0.0013917787,0.001924003],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000100776415,0.00011780867,0.00017237433,0.021751167,0.000092779126,0.00038866536,0.0001326776,0.0002174343,0.0035148286,0.0038331281,0.02060926,0.9490691],"study_design_scores_gemma":[0.000034748326,0.0001961599,0.0011125548,0.006370269,0.00018124291,0.0022187557,0.00019447308,0.00009592052,0.000770782,0.0038251462,0.9849761,0.000023918668],"about_ca_topic_score_codex":0.0007614782,"about_ca_topic_score_gemma":0.0017791832,"teacher_disagreement_score":0.004165261,"about_ca_system_score_codex":0.0003959836,"about_ca_system_score_gemma":0.0007701306,"threshold_uncertainty_score":0.013934195},"labels":[],"label_agreement":null},{"id":"W2148491085","doi":"10.2174/18715273113129990087","title":"Exploring the Role of Nerve Growth Factor in Multiple Sclerosis: Implications in Myelin Repair","year":2014,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"University of Manitoba","keywords":"Myelin; Multiple sclerosis; Neurotrophin; Nerve growth factor; Neurotrophic factors; Immunology; Demyelinating disease; Cell biology; Oligodendrocyte; Myelin basic protein; Microglia; Biology; Neuroscience; Central nervous system; Inflammation; Receptor","score_opus":0.17646486701172837,"score_gpt":0.3261742962155118,"score_spread":0.14970942920378344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148491085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01897607,0.971893,0.0008277808,0.0048964988,0.00044986224,0.000010293668,0.00007368879,0.000016530317,0.0028562346],"genre_scores_gemma":[0.13158363,0.86151093,0.0013123135,0.0015904539,0.00093439483,0.000026414938,0.00009704802,0.000005867185,0.0029389297],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998683,0.000029651468,0.000009082781,0.000025917063,0.000036398542,0.00003073143],"domain_scores_gemma":[0.999813,0.00003681959,0.000044157732,0.0000052990968,0.000050101007,0.00005073719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044028487,0.00041369413,0.0004954082,0.0006867586,0.0002640827,0.0011280526,0.00047831982,0.0010448686,0.0014813598],"category_scores_gemma":[0.0004234647,0.00012230153,0.00034689938,0.00088368554,0.0007036582,0.0011834014,0.00046979712,0.0012113261,0.000459469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023730344,0.0007280953,0.0107730115,0.013025273,0.00028826855,0.0031577772,0.0007716144,0.0016804256,0.12326139,0.030307455,0.023582567,0.7900511],"study_design_scores_gemma":[0.00038306904,0.005788847,0.068246275,0.0070593343,0.0009780262,0.009071092,0.0037864356,0.004375324,0.05450137,0.06551364,0.7800771,0.00021947638],"about_ca_topic_score_codex":0.0017397716,"about_ca_topic_score_gemma":0.0023335014,"teacher_disagreement_score":0.0017397716,"about_ca_system_score_codex":0.00091368344,"about_ca_system_score_gemma":0.0009859054,"threshold_uncertainty_score":0.0066292286},"labels":[],"label_agreement":null},{"id":"W2149587643","doi":"10.2174/1871527313666141130205514","title":"Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Metformin; Cognition; Mood; Medicine; Type 2 Diabetes Mellitus; Bioinformatics; Major depressive disorder; Psychology; Clinical psychology; Diabetes mellitus; Psychiatry; Endocrinology; Biology","score_opus":0.06830088830804812,"score_gpt":0.3110399721647896,"score_spread":0.2427390838567415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149587643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018833383,0.99876946,0.00006803613,0.00019613974,0.00009996173,0.000005186384,0.000019715928,0.000004922058,0.0006481695],"genre_scores_gemma":[0.0015900494,0.9977325,0.00014690115,0.00017533524,0.00009289711,0.000008861967,0.0000250085,9.134173e-7,0.0002273642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998542,0.00003422642,0.000033611446,0.000020677138,0.000043209882,0.000014021935],"domain_scores_gemma":[0.9997913,0.000121739155,0.000038355873,0.0000068255326,0.000027633629,0.000014079985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044660713,0.0005653495,0.0011039396,0.001867279,0.00023940204,0.0008079404,0.0006040262,0.00097207836,0.0029699083],"category_scores_gemma":[0.0006777172,0.00018270443,0.00074638275,0.001238677,0.0002534858,0.0007323879,0.0005503619,0.0011912312,0.000737527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014988103,0.000075934135,0.00023373104,0.042035867,0.0002521633,0.00032391457,0.000070210655,0.0002548082,0.0017623405,0.004048674,0.014664114,0.9361284],"study_design_scores_gemma":[0.000090366615,0.0002591276,0.0020451806,0.016318507,0.0006218419,0.0024741674,0.00009909981,0.00016282426,0.0014317533,0.0033737554,0.9730901,0.00003328621],"about_ca_topic_score_codex":0.00052838697,"about_ca_topic_score_gemma":0.0013759552,"teacher_disagreement_score":0.0029699083,"about_ca_system_score_codex":0.00033112045,"about_ca_system_score_gemma":0.0006728275,"threshold_uncertainty_score":0.009935379},"labels":[],"label_agreement":null},{"id":"W2151739538","doi":"10.2174/187152710793237386","title":"Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics","year":2010,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Heat shock proteins research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":105,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institutes of Health","keywords":"Neurodegeneration; Proteostasis; Substantia nigra; Pars compacta; Chaperone (clinical); Biology; Parkinson's disease; Chemical chaperone; Neuroprotection; Proteasome; Protein aggregation; Protein folding; Dopaminergic; Neuroscience; Cell biology; Unfolded protein response; Disease; Medicine; Dopamine; Endoplasmic reticulum; Pathology","score_opus":0.026660396564438114,"score_gpt":0.3306470657107122,"score_spread":0.30398666914627404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151739538","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01134213,0.96455204,0.0063021416,0.0043317396,0.0012964228,0.00022061805,0.00050222944,0.00034806438,0.011104482],"genre_scores_gemma":[0.059347503,0.9155962,0.0071790535,0.003417144,0.00081585324,0.00027549875,0.0009361961,0.00006224102,0.012370336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998266,0.000045348872,0.000014853102,0.000025334404,0.0000516604,0.00003624883],"domain_scores_gemma":[0.99988425,0.00002750662,0.000019916411,0.0000055049927,0.000041214586,0.000021533666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058704894,0.0007099833,0.0011604356,0.0011325296,0.00027405855,0.0009951409,0.0006065819,0.0010155234,0.0038677373],"category_scores_gemma":[0.00036294907,0.00024138257,0.00064848014,0.0005344704,0.00037176607,0.0009581672,0.0006025456,0.0021574444,0.0021088677],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013273386,0.0011454958,0.0007119772,0.009757796,0.000399763,0.0018029086,0.00031146788,0.003925651,0.106007546,0.03901502,0.07111311,0.7644819],"study_design_scores_gemma":[0.000574651,0.0022019602,0.0009988189,0.0011658099,0.0002234114,0.0012836414,0.00007949904,0.0013901859,0.0164953,0.008562875,0.96696067,0.000063131876],"about_ca_topic_score_codex":0.00043931702,"about_ca_topic_score_gemma":0.0013922594,"teacher_disagreement_score":0.0038677373,"about_ca_system_score_codex":0.00065418676,"about_ca_system_score_gemma":0.0004598796,"threshold_uncertainty_score":0.012938917},"labels":[],"label_agreement":null},{"id":"W2156826191","doi":"10.2174/1871527313666141130203823","title":"Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review","year":2015,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Treatment of Major Depression","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Major depressive disorder; Cognition; Executive dysfunction; Psychology; Clinical psychology; Neuropsychology; Psychosocial; Executive functions; Psychiatry","score_opus":0.049185383628827684,"score_gpt":0.36450575157018655,"score_spread":0.31532036794135887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156826191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000068180074,0.9995022,0.000027655979,0.0001282735,0.000058453363,0.000002859136,0.0000152153225,0.000002961206,0.00019425065],"genre_scores_gemma":[0.0004334113,0.99928766,0.00006845854,0.00006749283,0.00005651997,0.0000028890177,0.000017775319,5.1121907e-7,0.000065305336],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996917,0.00005732468,0.00008661797,0.00005264484,0.00009062719,0.000021136068],"domain_scores_gemma":[0.9988174,0.0007352304,0.00018064781,0.000020109263,0.00019763835,0.00004894314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008335817,0.00082715607,0.001841949,0.0029514553,0.0003089557,0.0012566126,0.0009823996,0.00096670876,0.0034912091],"category_scores_gemma":[0.0017983665,0.00033851442,0.00080058275,0.0032088154,0.00037574815,0.0012127657,0.00074618857,0.0011783757,0.00086017215],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008064128,0.000055784105,0.00032098568,0.06339454,0.000215596,0.0001412859,0.0000949336,0.00023251271,0.00037529407,0.0011621478,0.020099686,0.9138266],"study_design_scores_gemma":[0.000044514312,0.00020511843,0.0040420596,0.06645777,0.001456427,0.0026819503,0.00023475042,0.00021970765,0.00032221287,0.0027417636,0.9215431,0.000050552135],"about_ca_topic_score_codex":0.0019508536,"about_ca_topic_score_gemma":0.0040512914,"teacher_disagreement_score":0.0034912091,"about_ca_system_score_codex":0.0005748645,"about_ca_system_score_gemma":0.0019681829,"threshold_uncertainty_score":0.011679292},"labels":[],"label_agreement":null},{"id":"W2157533983","doi":"10.2174/1871527314666150225141229","title":"Effect of Probenecid on the Pain-Related Behaviour and Morphological Markers in Orofacial Formalin Test of the Rat","year":2015,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Orofacial pain; Probenecid; Test (biology); Psychology; Medicine; Pharmacology; Physical therapy; Biology","score_opus":0.009894698318001974,"score_gpt":0.23776199226680161,"score_spread":0.22786729394879965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157533983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876117,0.006916636,0.0009153853,0.0004045135,0.00015232054,0.000091971626,0.00070326123,0.00013441266,0.003069707],"genre_scores_gemma":[0.98269653,0.0063716997,0.0023046131,0.0002771369,0.00008277232,0.00017580063,0.0011179161,0.000025412079,0.0069480813],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998373,0.00002096614,0.000012548524,0.000030589337,0.000038154132,0.000060438793],"domain_scores_gemma":[0.99975926,0.00003732027,0.000063668296,0.00002269637,0.000041262094,0.000075806085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014351719,0.00062375795,0.00055064727,0.00040087622,0.00017096437,0.00018815626,0.00024623048,0.00050873955,0.0027082004],"category_scores_gemma":[0.0003072274,0.00018487779,0.0003590069,0.00031763868,0.0003541486,0.0003372673,0.00017066111,0.0009721896,0.0003011129],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024797418,0.00040219922,0.000245303,0.00018485564,0.000018984807,0.000180585,0.000053572534,0.0000939056,0.99163485,0.00007461368,0.00016912748,0.0044622878],"study_design_scores_gemma":[0.00027131772,0.018428372,0.015818784,0.00005857487,0.000091171125,0.00070926145,0.00013487691,0.00070420647,0.96030146,0.00012812647,0.003321792,0.000031994798],"about_ca_topic_score_codex":0.0012268663,"about_ca_topic_score_gemma":0.0027454474,"teacher_disagreement_score":0.0027082004,"about_ca_system_score_codex":0.00031592295,"about_ca_system_score_gemma":0.0003897714,"threshold_uncertainty_score":0.009059846},"labels":[],"label_agreement":null},{"id":"W2258997495","doi":"10.2174/1871527314666150317225205","title":"Immune System Induction of Nerve Growth Factor in an Animal Model of Multiple Sclerosis: Implications in Re-Myelination and Myelin RepairATION AND MYELIN REPAIR","year":2015,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neurogenesis and neuroplasticity mechanisms","field":"Neuroscience","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Manitoba Health","funders":"","keywords":"Multiple sclerosis; Myelin; Neuroscience; Myelin sheath; Immune system; Nerve growth factor; Medicine; Biology; Immunology; Central nervous system; Internal medicine","score_opus":0.0842717414883922,"score_gpt":0.25977043515744375,"score_spread":0.17549869366905155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2258997495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99316627,0.0034593255,0.0013054946,0.00014032291,0.00006852287,0.000058954865,0.00020374266,0.000059047314,0.0015382508],"genre_scores_gemma":[0.98867744,0.003288519,0.0030288901,0.000067584675,0.00003567717,0.00015531102,0.00033423802,0.000010625278,0.0044017443],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998154,0.000029790568,0.000017521459,0.0000355598,0.000052170566,0.000049525413],"domain_scores_gemma":[0.9998846,0.000009974,0.000030439138,0.000011453693,0.00001516306,0.000048400707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022074608,0.00058375316,0.00042458135,0.0007581301,0.00022213788,0.0002704366,0.00019177348,0.00043856658,0.0013870035],"category_scores_gemma":[0.00008971184,0.00013712392,0.00029503307,0.00028085476,0.00049266743,0.00030017758,0.0002042602,0.0010945158,0.0002691387],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007102802,0.0003362689,0.0004889668,0.000092507915,0.000009952862,0.00016793213,0.00003147327,0.000041030016,0.9954853,0.000105645944,0.00003988407,0.0024907868],"study_design_scores_gemma":[0.000121033234,0.008489229,0.015222911,0.000045539997,0.00008474288,0.00079537166,0.00011669038,0.00065065996,0.9712227,0.0002174708,0.0030199212,0.000013788125],"about_ca_topic_score_codex":0.00060704723,"about_ca_topic_score_gemma":0.0015588662,"teacher_disagreement_score":0.0013870035,"about_ca_system_score_codex":0.00038007073,"about_ca_system_score_gemma":0.0003814441,"threshold_uncertainty_score":0.004639983},"labels":[],"label_agreement":null},{"id":"W2303485966","doi":"10.2174/1871527315666160321104916","title":"A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome","year":2016,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Nerve growth factor; Basal forebrain; Cholinergic neuron; Cholinergic; Neuroscience; Alzheimer's disease; Cerebral cortex; Acetylcholine; Amyloid precursor protein; Hippocampus; Biology; Internal medicine; Endocrinology; Medicine; Disease; Receptor","score_opus":0.03308793216589056,"score_gpt":0.3135697627147458,"score_spread":0.2804818305488552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2303485966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002447833,0.99897885,0.00007199093,0.000100203855,0.00006331475,0.0000026901726,0.000013792118,0.000004010429,0.00052041083],"genre_scores_gemma":[0.0008446607,0.9986822,0.0000969654,0.00005578353,0.00003360597,0.0000025056486,0.000016540356,5.016026e-7,0.00026716432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999306,0.000009437462,0.000015119039,0.000012753149,0.000023562052,0.0000084216035],"domain_scores_gemma":[0.99991596,0.000032491997,0.000019493347,0.000002460345,0.000020401636,0.000009093017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022977294,0.0005796863,0.00079802395,0.001356876,0.00016659049,0.0005390412,0.0003736467,0.0005827142,0.0023385533],"category_scores_gemma":[0.0002758153,0.0001657136,0.00034961104,0.0013208034,0.00023853352,0.0006102174,0.00046147476,0.00080847717,0.00091327785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012168474,0.000057059857,0.0004069937,0.02814898,0.00016217772,0.0007337721,0.000107514905,0.00024170354,0.005249912,0.0027866454,0.0138252145,0.9481583],"study_design_scores_gemma":[0.000036081135,0.00018500948,0.003585528,0.0070608007,0.00039895083,0.0065901643,0.00014964861,0.000096611366,0.0017411985,0.0028488848,0.9772784,0.000028663915],"about_ca_topic_score_codex":0.00087219843,"about_ca_topic_score_gemma":0.0017590759,"teacher_disagreement_score":0.0023385533,"about_ca_system_score_codex":0.00028769436,"about_ca_system_score_gemma":0.00063179206,"threshold_uncertainty_score":0.007823229},"labels":[],"label_agreement":null},{"id":"W2321067239","doi":"10.2174/187152709788680652","title":"Blood-Brain Barrier Transport of Drugs for the Treatment of Brain Diseases","year":2009,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Diet and metabolism studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Angiochem (Canada)","funders":"","keywords":"Blood–brain barrier; Parenchyma; Central nervous system; Endogeny; Brain function; Neuroscience; Homeostasis; Brain disease; Hormone; Brain Cell; Disease; Medicine; Biology; Pharmacology; Endocrinology; Internal medicine; Pathology","score_opus":0.024278816644669004,"score_gpt":0.3072041665301513,"score_spread":0.2829253498854823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321067239","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018327251,0.99639857,0.00027136676,0.00018285439,0.00017193511,0.000011969917,0.000020401829,0.000010874668,0.0027487052],"genre_scores_gemma":[0.000833666,0.9965581,0.0005075132,0.00013142753,0.000105872205,0.000013250867,0.00003599428,0.0000027967847,0.0018113023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998135,0.0000350653,0.000024954104,0.000030125953,0.000082195744,0.000014168067],"domain_scores_gemma":[0.99981457,0.00007896717,0.000028119792,0.000008315644,0.000052846488,0.000017266044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005032456,0.00094751525,0.0016708632,0.0029127821,0.00036032632,0.0008323602,0.00089433056,0.0011579522,0.0064302897],"category_scores_gemma":[0.00046782414,0.00025269724,0.0004736653,0.0029638698,0.0005135412,0.0015291527,0.0006483059,0.0015557358,0.0052443165],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008000466,0.00015690045,0.00009095566,0.014678444,0.000080202975,0.00034901933,0.00007325749,0.00035807074,0.0051723705,0.0043103825,0.025627285,0.9490231],"study_design_scores_gemma":[0.00002293091,0.00009836673,0.00047778338,0.0020475518,0.000071514405,0.0016129889,0.000046139096,0.00007766799,0.0012517316,0.0014482371,0.99282914,0.000015930851],"about_ca_topic_score_codex":0.0009554342,"about_ca_topic_score_gemma":0.0017691726,"teacher_disagreement_score":0.0064302897,"about_ca_system_score_codex":0.00054760167,"about_ca_system_score_gemma":0.0008863304,"threshold_uncertainty_score":0.021511495},"labels":[],"label_agreement":null},{"id":"W2398320055","doi":"10.2174/187152710793361577","title":"Commentary","year":2010,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Reproductive System and Pregnancy","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vitamin D and neurology; Sunlight; Multiple sclerosis; Major histocompatibility complex; Allele; Pregnancy; Lower risk; vitamin D deficiency; Environmental health; Biology; Demography; Medicine; Genetics; Immunology; Gene; Internal medicine; Endocrinology","score_opus":0.0066689940132700935,"score_gpt":0.21991785034440944,"score_spread":0.21324885633113935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398320055","genre_codex":"editorial","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038951702,0.018057492,0.00070011575,0.35496014,0.46317527,0.00017124633,0.0027898068,0.0005493786,0.159207],"genre_scores_gemma":[0.0060129105,0.02111223,0.00093295646,0.38539198,0.18424934,0.00028609534,0.0030471962,0.000569898,0.39839742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973368,0.0005664448,0.00019952448,0.00043906108,0.0010603202,0.00039783586],"domain_scores_gemma":[0.9889181,0.002815622,0.00048224608,0.00073390227,0.004738188,0.0023119033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002526101,0.00084050244,0.0009778147,0.0014709688,0.0019218231,0.005099351,0.00296236,0.0095987795,0.36007622],"category_scores_gemma":[0.023887277,0.0004038221,0.0012298784,0.0010438085,0.0012729549,0.003283679,0.0027287197,0.0075954893,0.15027452],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017086326,0.000006072236,0.000040180737,0.00012864423,0.0000035672638,0.00006464352,0.000019893072,0.000009140638,0.000023966988,0.0012681088,0.9820509,0.016367799],"study_design_scores_gemma":[0.000008593633,0.0000050904855,0.00008372012,0.0002383152,0.0000029374191,0.00011365312,0.0000356587,0.0000070686324,0.000022349192,0.0007119743,0.9987675,0.0000032017933],"about_ca_topic_score_codex":0.0039999797,"about_ca_topic_score_gemma":0.0047920505,"teacher_disagreement_score":0.6399238,"about_ca_system_score_codex":0.0025457756,"about_ca_system_score_gemma":0.006772195,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W2528385559","doi":"10.2174/1871527315666161003170312","title":"Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study","year":2016,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Treatment of Major Depression","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Major depressive disorder; Psychology; Cognition; Antidepressant; Psychiatry; Depression (economics); Beck Depression Inventory; Verbal memory; Clinical psychology; Anxiety","score_opus":0.01296389571564362,"score_gpt":0.24528809526028358,"score_spread":0.23232419954463995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2528385559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988851,0.00035065127,0.00006972203,0.000020836256,0.0000086009995,0.000040372914,0.0005125679,0.0000025658342,0.00010968366],"genre_scores_gemma":[0.9981236,0.00020797382,0.00015107519,0.00005913578,0.000019210793,0.000048405393,0.0012549635,0.0000026081457,0.00013300616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987796,0.00046921417,0.00015632114,0.0002622184,0.00020221397,0.00013046803],"domain_scores_gemma":[0.99706,0.00054274173,0.000983998,0.00044779014,0.00037299693,0.0005923719],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021003976,0.0005499007,0.001104707,0.0004929909,0.0005699147,0.00082661555,0.0005085342,0.00073602056,0.0012157104],"category_scores_gemma":[0.0036787011,0.0005481184,0.0017439672,0.0007074071,0.00026266722,0.00042302295,0.00052836124,0.0007966229,0.00035541694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005100142,0.00047854756,0.9902975,0.000044227716,0.0012276934,0.00014292153,0.00014699304,0.000037651775,0.00058598444,0.000008695534,0.00015954256,0.0017701035],"study_design_scores_gemma":[0.0004048247,0.0015502549,0.9969921,0.000008636902,0.00043587203,0.00021645139,0.000097857395,0.00009436737,0.000055508262,0.0000066821303,0.0001290287,0.000008321901],"about_ca_topic_score_codex":0.0041959793,"about_ca_topic_score_gemma":0.0050994675,"teacher_disagreement_score":0.0041959793,"about_ca_system_score_codex":0.00031446043,"about_ca_system_score_gemma":0.0004696182,"threshold_uncertainty_score":0.0111081},"labels":[],"label_agreement":null},{"id":"W2800740578","doi":"10.2174/1871527317666180419115029","title":"Current and Promising Therapies in Autosomal Recessive Ataxias","year":2018,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Ataxia; Ataxia-telangiectasia; Medicine; Disease; Cerebellar ataxia; Bioinformatics; Neuroscience; Genetics; Biology; Pathology; Psychiatry","score_opus":0.05530086348238081,"score_gpt":0.3284631310583688,"score_spread":0.27316226757598794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800740578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018196089,0.99795973,0.00013099928,0.00028446657,0.00017660962,0.000005029197,0.000018713017,0.000009848962,0.0012326887],"genre_scores_gemma":[0.0011700202,0.99729306,0.00028318042,0.0002631037,0.00014084928,0.000008307283,0.000043058117,0.0000019556328,0.0007963804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998827,0.000021378897,0.000019914976,0.000019438585,0.00004177996,0.000014698617],"domain_scores_gemma":[0.9998566,0.00006027511,0.00002196946,0.000004650551,0.000042660005,0.000013872386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034244295,0.00071146793,0.0007374254,0.0018922403,0.0002479467,0.0005965559,0.00057299586,0.0008402702,0.0040139062],"category_scores_gemma":[0.00041197648,0.0001397669,0.00045084194,0.00096760393,0.00026021645,0.0007731539,0.000541781,0.0015994248,0.001633082],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008518311,0.00008892089,0.00014278389,0.012040891,0.00006252525,0.00037401728,0.000068131994,0.00026663183,0.002470621,0.0026796835,0.023887768,0.9578328],"study_design_scores_gemma":[0.00002683821,0.00014558023,0.00075364904,0.0050148917,0.0001393583,0.0028866513,0.0000650874,0.000112512,0.0008475153,0.00222183,0.98777163,0.000014420542],"about_ca_topic_score_codex":0.000636871,"about_ca_topic_score_gemma":0.0016936646,"teacher_disagreement_score":0.0040139062,"about_ca_system_score_codex":0.00042172783,"about_ca_system_score_gemma":0.0005787682,"threshold_uncertainty_score":0.013427794},"labels":[],"label_agreement":null},{"id":"W2806727800","doi":"10.2174/1871527317666180605120244","title":"A Longitudinal Study of Alterations of S100B, sRAGE and Fas Ligand in Association to Olanzapine Medication in a Sample of First Episode Patients with Schizophrenia","year":2018,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fas ligand; Schizophrenia (object-oriented programming); Rage (emotion); Neuroinflammation; Internal medicine; Medicine; Psychosis; Antipsychotic; Olanzapine; Receptor; Apoptosis; Autoantibody; Neuropathology; Fas receptor; Endocrinology; Oncology; Psychology; Immunology; Psychiatry; Inflammation; Neuroscience; Chemistry; Programmed cell death","score_opus":0.01408217252466871,"score_gpt":0.24793389258021145,"score_spread":0.23385172005554275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806727800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999706,0.00007372071,0.000028383729,0.000017496048,0.000003119399,0.0000050325466,0.00008631212,0.0000014727327,0.000078522826],"genre_scores_gemma":[0.9994869,0.00005385418,0.00004510598,0.000019355637,0.0000038673297,0.0000075594835,0.0001974883,0.000001277779,0.00018458265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972326,0.000045413773,0.000028844901,0.00008409797,0.00006209529,0.000056320132],"domain_scores_gemma":[0.99915576,0.00006902821,0.00032338232,0.000058361875,0.00015257142,0.00024087584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003589193,0.00037688104,0.00044313987,0.0009121169,0.00091857865,0.00069627515,0.00024852515,0.000572805,0.0014052752],"category_scores_gemma":[0.0011658119,0.00037122014,0.00038039894,0.0006390806,0.00025191158,0.00040043943,0.0004126964,0.0006865773,0.0003310851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002431419,0.00010577211,0.9963929,0.000006730755,0.000043422533,0.00027075363,0.0003088213,0.00001278544,0.0015317966,0.0000070474634,0.00005075771,0.0010260813],"study_design_scores_gemma":[0.0000057765706,0.00019438346,0.9987349,0.0000026590235,0.000016245382,0.0005292424,0.00029548837,0.000038402595,0.00008634595,0.000006992318,0.000086294014,0.0000032348203],"about_ca_topic_score_codex":0.006240629,"about_ca_topic_score_gemma":0.0073417625,"teacher_disagreement_score":0.006240629,"about_ca_system_score_codex":0.00052109634,"about_ca_system_score_gemma":0.00040411478,"threshold_uncertainty_score":0.012408614},"labels":[],"label_agreement":null},{"id":"W2900218198","doi":"10.2174/1871527317666181105105113","title":"Different Food Odors Control Brain Connectivity in Impulsive Children","year":2018,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Consejo Nacional de Ciencia y Tecnología","keywords":"Psychology; Cingulum (brain); Precuneus; Insula; Functional magnetic resonance imaging; Sensory system; Neuroscience; Odor; Insular cortex; Somatosensory system; Postcentral gyrus; Posterior cingulate; Audiology; Supplementary motor area; Orbitofrontal cortex; Prefrontal cortex; Cognition; Medicine; Magnetic resonance imaging; Fractional anisotropy","score_opus":0.03310640510853171,"score_gpt":0.2412322173781534,"score_spread":0.20812581226962168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900218198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995728,0.000042774864,0.0000688046,0.000009490132,0.0000010308462,0.0000028358616,0.00007196316,0.0000032175456,0.00022706306],"genre_scores_gemma":[0.9992859,0.000057751982,0.00020278509,0.000010668708,0.0000015346252,0.000009290941,0.00012605582,0.000004464683,0.00030162436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99987376,0.000014528545,0.000007647948,0.000049252336,0.0000256838,0.000029217883],"domain_scores_gemma":[0.9996779,0.00008826921,0.00014405919,0.000017051494,0.000020059024,0.000052728872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016977557,0.0004673748,0.00024679553,0.00059793174,0.000252319,0.0005684367,0.0001982891,0.0002781601,0.0028110165],"category_scores_gemma":[0.0008212497,0.00022050102,0.0002787237,0.00028091663,0.00040757586,0.0002463512,0.00035612818,0.00031733327,0.00014008043],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013871446,0.00036093785,0.9306111,0.00013930611,0.00015424487,0.0031567018,0.002083174,0.0004015185,0.048155453,0.00036955415,0.00021108144,0.012969808],"study_design_scores_gemma":[0.000011149085,0.00015803917,0.99585044,0.000009167463,0.000044450782,0.0011737777,0.00061151606,0.0001763303,0.0016853734,0.000106471234,0.00016755454,0.0000058590686],"about_ca_topic_score_codex":0.003877149,"about_ca_topic_score_gemma":0.00422186,"teacher_disagreement_score":0.003877149,"about_ca_system_score_codex":0.0003717625,"about_ca_system_score_gemma":0.00023737217,"threshold_uncertainty_score":0.009403765},"labels":[],"label_agreement":null},{"id":"W2901651562","doi":"10.2174/1871527317666181119115532","title":"A New Schizophrenia Model: Immune Activation is Associated with the Induction of Different Neurotoxic Products which Together Determine Memory Impairments and Schizophrenia Symptom Dimensions","year":2018,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Tryptophan and brain disorders","field":"Neuroscience","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Asahi Glass Foundation","keywords":"Schizophrenia (object-oriented programming); Neuroscience; Psychology; Medicine; Psychiatry","score_opus":0.015378636116954392,"score_gpt":0.23011531357064077,"score_spread":0.21473667745368638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901651562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734784,0.002098637,0.016834164,0.0022975456,0.00010564053,0.00015260113,0.0010893625,0.00019353168,0.0037501787],"genre_scores_gemma":[0.9898273,0.0011137637,0.0059208544,0.00046056858,0.00006186245,0.00009512141,0.0006475921,0.00001273134,0.0018603613],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99982774,0.00003732856,0.000012881706,0.000055845383,0.000036763642,0.00002944507],"domain_scores_gemma":[0.99985576,0.000016836397,0.000052153617,0.000019780693,0.000014578804,0.00004087187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034420204,0.0008399372,0.00041317032,0.0007183583,0.00037744085,0.0005362549,0.00031571672,0.00032674122,0.0019395817],"category_scores_gemma":[0.00035694783,0.00015687941,0.0004285805,0.00029543275,0.0007513139,0.0007287932,0.00067962037,0.000582845,0.00028797207],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007622001,0.0023738898,0.45071164,0.0009282935,0.0016013352,0.009930886,0.0016475278,0.007446904,0.35093236,0.069168255,0.0065486715,0.09108817],"study_design_scores_gemma":[0.001361578,0.007573526,0.7273401,0.0004316563,0.0011074308,0.045965474,0.0018170845,0.050497506,0.02018399,0.118704215,0.024745269,0.00027225236],"about_ca_topic_score_codex":0.0031988749,"about_ca_topic_score_gemma":0.0031802184,"teacher_disagreement_score":0.0031988749,"about_ca_system_score_codex":0.00065041287,"about_ca_system_score_gemma":0.0012167228,"threshold_uncertainty_score":0.0064885616},"labels":[],"label_agreement":null},{"id":"W2988446212","doi":"10.2174/1871527318666191114092007","title":"Structurally Related Edaravone Analogues: Synthesis, Antiradical, Antioxidant, and Copper-Chelating Properties","year":2019,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; Université de Moncton","funders":"New Brunswick Innovation Foundation; Canada Foundation for Innovation; Fondation Brain Canada; ALS Society of Canada","keywords":"Edaravone; Chemistry; Chelation; Antioxidant; Moiety; Electronegativity; Copper; Combinatorial chemistry; Organic chemistry; Pharmacology; Medicine","score_opus":0.015175568929709695,"score_gpt":0.2401695910815678,"score_spread":0.2249940221518581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988446212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9139328,0.058470245,0.01392315,0.00036742407,0.00020851706,0.0006563274,0.0016933082,0.00008860352,0.010659567],"genre_scores_gemma":[0.9435684,0.029829323,0.018286502,0.00024213213,0.00007661877,0.00027886144,0.0018051716,0.000035999063,0.005876969],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991214,0.000015557718,0.000010924574,0.000019909065,0.000016269107,0.000025194315],"domain_scores_gemma":[0.9998789,0.000018571987,0.00003159687,0.000017331133,0.000033327524,0.000020233761],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020568729,0.0005597141,0.00031297278,0.00037943808,0.0001543438,0.00024657513,0.00042234702,0.000335899,0.0019575628],"category_scores_gemma":[0.00025209587,0.00014216673,0.00043556123,0.00037643866,0.0002365978,0.00039939178,0.0002335853,0.0005519762,0.00058399606],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068130257,0.00034085583,0.0007195687,0.0013150102,0.00007706998,0.0009792253,0.00015144757,0.0017635227,0.9458712,0.0010737341,0.00034968922,0.046677385],"study_design_scores_gemma":[0.0004326294,0.014922874,0.005831848,0.00022232695,0.00029422232,0.0033984699,0.00017382957,0.00085197535,0.9022798,0.0007908913,0.07074746,0.00005381108],"about_ca_topic_score_codex":0.00035752103,"about_ca_topic_score_gemma":0.00067043805,"teacher_disagreement_score":0.0019575628,"about_ca_system_score_codex":0.0002622333,"about_ca_system_score_gemma":0.00034046423,"threshold_uncertainty_score":0.0065487027},"labels":[],"label_agreement":null},{"id":"W3035099580","doi":"10.2174/1871527319666200613222502","title":"Lisdexamfetamine Alters BOLD-fMRI Activations Induced by Odor Cues in Impulsive Children","year":2020,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Olfactory and Sensory Function Studies","field":"Neuroscience","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Precuneus; Psychology; Cuneus; Neuroscience; Impulsivity; Posterior cingulate; Cingulate cortex; Anterior cingulate cortex; Brain activity and meditation; Functional magnetic resonance imaging; Cognition; Developmental psychology; Central nervous system; Electroencephalography","score_opus":0.05678015587001778,"score_gpt":0.2516429689812735,"score_spread":0.1948628131112557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035099580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9997609,0.000058965914,0.000031483418,0.0000075575044,9.0185284e-7,0.0000030413858,0.000029038922,0.0000031239883,0.00010492651],"genre_scores_gemma":[0.99934715,0.00010777853,0.00015717527,0.000016906088,0.0000013935157,0.00000896663,0.000060196267,0.000001977145,0.0002984395],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999652,0.000005786909,0.0000028938837,0.000010755814,0.0000076115953,0.000007751808],"domain_scores_gemma":[0.99989045,0.00002945551,0.00004820167,0.0000042773704,0.000006383641,0.00002121291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008495407,0.00022003897,0.00014208026,0.00018934946,0.00009258724,0.00015870853,0.000081274586,0.00021341657,0.0013071358],"category_scores_gemma":[0.00028952223,0.000101965314,0.00012020042,0.00011724602,0.00015799601,0.000085298016,0.00010791931,0.00020142969,0.000068955334],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014124569,0.0016789597,0.38411447,0.00032453984,0.00017803797,0.0035691438,0.001151485,0.00019633342,0.55933636,0.00016477493,0.00026943712,0.03489189],"study_design_scores_gemma":[0.000075770266,0.0028609517,0.9639245,0.000012465467,0.000078456374,0.0017513857,0.00022296536,0.0002067681,0.030311774,0.000029444549,0.0005179121,0.000007654424],"about_ca_topic_score_codex":0.0012411275,"about_ca_topic_score_gemma":0.002026143,"teacher_disagreement_score":0.0013071358,"about_ca_system_score_codex":0.00016938346,"about_ca_system_score_gemma":0.00012362965,"threshold_uncertainty_score":0.0043727756},"labels":[],"label_agreement":null},{"id":"W3039244359","doi":"10.2174/1871527319666200702143719","title":"Resolution-Associated Molecular Patterns (RAMPs) as Endogenous Regulators of Glia Functions in Neuroinflammatory Disease","year":2020,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Microglia; Autocrine signalling; Paracrine signalling; Biology; Neuroinflammation; Neuroscience; Astrocyte; Endogeny; Cell biology; Inflammation; Central nervous system; Receptor; Immunology","score_opus":0.03768592847846626,"score_gpt":0.2667156541142575,"score_spread":0.22902972563579127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039244359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33606267,0.6423,0.009854626,0.0015117113,0.00043342903,0.00008843238,0.00022761479,0.00018768471,0.009333826],"genre_scores_gemma":[0.72774994,0.2598791,0.0062917173,0.00051469414,0.0005328255,0.000046676967,0.00028238088,0.000024367686,0.004678257],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99989104,0.000025926873,0.000016288232,0.000016330445,0.000025841315,0.000024453188],"domain_scores_gemma":[0.9998884,0.000012237568,0.00006214548,0.0000043502346,0.000014115867,0.000018753903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019990918,0.00043773878,0.00024438842,0.0005787097,0.00013867607,0.00054201286,0.00020351584,0.00037456542,0.0008247918],"category_scores_gemma":[0.00013386513,0.00009217381,0.00024329782,0.00038649203,0.00034602507,0.00055377505,0.00045990176,0.00042402482,0.00030949374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015007308,0.00018705781,0.008925246,0.0040007313,0.00014187855,0.0053161043,0.00060348056,0.0006368605,0.69993734,0.007842492,0.0021245938,0.26878345],"study_design_scores_gemma":[0.0002017259,0.0042291866,0.16983055,0.0020489723,0.0010087987,0.05044783,0.0022357043,0.002933859,0.45765767,0.013966916,0.29525325,0.00018559596],"about_ca_topic_score_codex":0.00015481384,"about_ca_topic_score_gemma":0.00020813955,"teacher_disagreement_score":0.0008247918,"about_ca_system_score_codex":0.00021646787,"about_ca_system_score_gemma":0.00014352499,"threshold_uncertainty_score":0.0027591586},"labels":[],"label_agreement":null},{"id":"W4224250926","doi":"10.2174/1871527321666220418114846","title":"Treatment and Management of Autosomal Recessive Cerebellar Ataxias: Current Advances and Future Perspectives","year":2022,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec","funders":"","keywords":"Medicine; Dysmetria; Disease; Dysarthria; Quality of life (healthcare); Cerebellar ataxia; Neuroscience; Ataxia; Bioinformatics; Pathology; Psychology; Biology; Audiology; Psychiatry","score_opus":0.033259804679101404,"score_gpt":0.31280294266007785,"score_spread":0.27954313798097646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224250926","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100455385,0.99894625,0.00010636809,0.00025483762,0.000089968824,0.00000238687,0.0000073057795,0.00000602001,0.00048641837],"genre_scores_gemma":[0.00065612915,0.99847454,0.0002625647,0.00019135371,0.00016053685,0.0000053560584,0.000020492493,0.0000017015522,0.00022734806],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998153,0.000039362756,0.000029174465,0.000034308847,0.00006089174,0.00002099403],"domain_scores_gemma":[0.9997104,0.0001495398,0.000042740172,0.000006673183,0.00006240081,0.00002820124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060847506,0.0009860275,0.0013694878,0.0016240072,0.00025744445,0.00093428086,0.00097416627,0.001200527,0.002617275],"category_scores_gemma":[0.0006474297,0.00015911083,0.00057248,0.0011607944,0.00047569966,0.001109017,0.00066655205,0.0017363556,0.0012457127],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007986423,0.00010271811,0.00012793232,0.009580994,0.000065418506,0.00027328247,0.00003818139,0.00039418935,0.00075832347,0.0017187174,0.014939976,0.9719205],"study_design_scores_gemma":[0.00006790213,0.00033375472,0.0017427431,0.012235755,0.00033925788,0.0049618436,0.00014285899,0.00035447459,0.0007038871,0.0047773253,0.9742993,0.000040912302],"about_ca_topic_score_codex":0.00083564117,"about_ca_topic_score_gemma":0.0017418658,"teacher_disagreement_score":0.002617275,"about_ca_system_score_codex":0.0005689963,"about_ca_system_score_gemma":0.0006862192,"threshold_uncertainty_score":0.008755624},"labels":[],"label_agreement":null},{"id":"W4280560399","doi":"10.2174/1871527321666220511205231","title":"The Emerging Role of Marine Natural Products for the Treatment ofParkinson’s Disease","year":2022,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Protein Hydrolysis and Bioactive Peptides","field":"Biochemistry, Genetics and Molecular Biology","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"JSS Academy of Higher Education and Research","keywords":"Neuroprotection; Pars compacta; Parkinson's disease; Substantia nigra; Dopaminergic; Disease; Natural product; Medicine; Dopamine; Pharmacology; Neuroscience; Biology; Bioinformatics; Chemistry; Biochemistry; Internal medicine","score_opus":0.015612172752748139,"score_gpt":0.27072579096981586,"score_spread":0.25511361821706774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280560399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026033865,0.9985337,0.000090780275,0.00016378456,0.00010887972,0.0000048666,0.000022971373,0.000006614714,0.0008079576],"genre_scores_gemma":[0.0011710572,0.99817884,0.00014541167,0.00011401645,0.00007816129,0.0000053739523,0.000025108773,0.0000010885856,0.0002810697],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99987197,0.000020961088,0.000022743608,0.00002249275,0.000048288886,0.0000135667715],"domain_scores_gemma":[0.99982846,0.000080319915,0.000023566452,0.000004685866,0.000046108275,0.000016834492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034755497,0.00053050043,0.00087597006,0.002313489,0.00022173922,0.00073399453,0.0004332877,0.0006593708,0.0029733498],"category_scores_gemma":[0.00040032974,0.00015372664,0.00048032127,0.001817758,0.00025232357,0.0008444742,0.0005252445,0.0011870747,0.0010159086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001027904,0.00010752357,0.00021918706,0.03493599,0.0001379218,0.00036011543,0.00010253398,0.00027962012,0.0045611616,0.002966717,0.013934145,0.9422923],"study_design_scores_gemma":[0.00003817276,0.00023926308,0.0017276745,0.005847667,0.00030454897,0.0021289778,0.00010153778,0.00013790462,0.0014254982,0.0017375821,0.986285,0.000026197327],"about_ca_topic_score_codex":0.0007954559,"about_ca_topic_score_gemma":0.0014094441,"teacher_disagreement_score":0.0029733498,"about_ca_system_score_codex":0.00028568594,"about_ca_system_score_gemma":0.0007044553,"threshold_uncertainty_score":0.009946823},"labels":[],"label_agreement":null},{"id":"W4301394383","doi":"10.2174/1871527322666221004113752","title":"Circadian Rhythm and Risk of Hemorrhagic Transformation after AcuteIschemic Stroke Treated with Intravenous Thrombolysis - A SystematicReview","year":2022,"lang":"en","type":"review","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Thrombolysis; Medicine; Circadian rhythm; Stroke (engine); Rhythm; Ischemic stroke; Anesthesia; Cardiology; Internal medicine; Ischemia; Myocardial infarction","score_opus":0.024172210997848633,"score_gpt":0.263017355582275,"score_spread":0.23884514458442638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4301394383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017365889,0.9970149,0.00011284444,0.00019842778,0.00014256129,0.00019335137,0.0004175673,0.000007644941,0.0001761386],"genre_scores_gemma":[0.019795747,0.9786985,0.00030252358,0.0003171442,0.000108629974,0.00038767894,0.00029800046,0.0000057997427,0.00008597461],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9950677,0.0016462664,0.0019077439,0.00048778058,0.00071805675,0.00017247009],"domain_scores_gemma":[0.96725,0.024129776,0.0059575476,0.00045620918,0.0019678797,0.00023848284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006389002,0.0012518341,0.0059882184,0.00779029,0.0004756117,0.002276671,0.001492337,0.00130139,0.0033970354],"category_scores_gemma":[0.040143207,0.00091408176,0.0063491147,0.009069901,0.00069350796,0.0017018644,0.0012750869,0.0008040855,0.00027343346],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015905587,0.0000149991165,0.001564204,0.96607167,0.008763843,0.00008725331,0.00021539108,0.000091879505,0.00008260293,0.00013432158,0.0012254743,0.02158932],"study_design_scores_gemma":[0.00017141055,0.00024240123,0.0129923625,0.8773217,0.09147694,0.0005251196,0.00046095447,0.00011200884,0.00016332557,0.00026392954,0.016214708,0.00005520047],"about_ca_topic_score_codex":0.008956905,"about_ca_topic_score_gemma":0.016524363,"teacher_disagreement_score":0.008956905,"about_ca_system_score_codex":0.0029526004,"about_ca_system_score_gemma":0.009051059,"threshold_uncertainty_score":0.03378868},"labels":[],"label_agreement":null},{"id":"W650803130","doi":"10.2174/1871527311211080001","title":"Conference Report (11th International Conference on Neuroprotective Agents, Wendake, Quebec City, Quebec, Canada, Sept 30-Oct 3, 2012)","year":2013,"lang":"en","type":"article","venue":"CNS & Neurological Disorders - Drug Targets","topic":"Neurological Disease Mechanisms and Treatments","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuroprotection; Library science; Political science; Medicine; Pharmacology; Computer science","score_opus":0.03430648943377635,"score_gpt":0.257333095342138,"score_spread":0.22302660590836165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W650803130","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010938675,0.07555307,0.0053890566,0.10803083,0.13152447,0.0037345532,0.044237252,0.001391162,0.619201],"genre_scores_gemma":[0.009414646,0.012635904,0.002056692,0.0071864817,0.00435487,0.0003571466,0.00961559,0.00017877361,0.9541999],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988372,0.00006413709,0.000039295453,0.000100200254,0.0006374588,0.00032166438],"domain_scores_gemma":[0.99593866,0.00007137486,0.00008284857,0.00007041789,0.0030093517,0.0008273804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025061734,0.0013782805,0.00086857134,0.0011912709,0.0028757052,0.0042151357,0.001664036,0.0036094736,0.20001803],"category_scores_gemma":[0.0018524315,0.0003984578,0.0012022742,0.0010683241,0.00054647226,0.0010430306,0.001202138,0.0026482793,0.059871517],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016461204,0.00011112415,0.00043140491,0.000101429236,0.00001558919,0.000101764774,0.000016508533,0.00006817526,0.0005051905,0.00020482979,0.9722659,0.026013603],"study_design_scores_gemma":[0.000077866105,0.000110532084,0.0030877884,0.00010602613,0.00003049365,0.00008842778,0.00007832922,0.00008254513,0.00067413185,0.00013394972,0.99551266,0.000017199067],"about_ca_topic_score_codex":0.5224069,"about_ca_topic_score_gemma":0.7653507,"teacher_disagreement_score":0.5224069,"about_ca_system_score_codex":0.00843386,"about_ca_system_score_gemma":0.029564602,"threshold_uncertainty_score":0.96081156},"labels":[],"label_agreement":null}]}